Incorporating anti-MAL antibodies into current antibody panels to detect MAL, either in biopsies or, as a non-invasive procedure, in human body fluids or waste matter [296,297], might provide a prognostic/diagnostic tool for cancer patients that can be used in routine clinical practice [257,261,270,286,287]. Here, MAL is linked to cancer.